Deoxyschizandrin suppresses dss-induced ulcerative colitis in mice. 2016

Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
Changchun University of Chinese Medicine, Changchun Jingyue Street, Boshuo Road 1035, Changchun, Jilin, China.

OBJECTIVE Deoxyschizandrin as one of the most important component of Schisandra chinensis (Turcz.) Baill plays an immunomodulatory role in a variety of diseases, yet its role in ulcerative colitis remains to be elucidated. We aimed to investigate the role of deoxyschizandrin in DSS-induced ulcerative colitis in mice. METHODS In the present study, an inflammation model of cells was constructed to confirm the anti-inflammatory effect of deoxyschizandrin. Then a mouse model with Dextran sulfate sodium sulfate (DSS)-induced ulcerative colitis was constructed, and the effects of deoxyschizandrin on mouse colon inflammation, apoptosis, and CD4 T lymphocyte infiltration in ulcerative colitis were examined. RESULTS Deoxyschizandrin could improve the symptoms of ulcerative colitis, determined by hematoxylin-eosin (HE) staining and histopathological scores. Moreover, deoxyschizandrin reduced the levels of inflammatory cytokines, suppressed CD4 T cell infiltration, and effectively inhibited apoptosis in the colon of DSS-induced ulcerative colitis mice. CONCLUSIONS In summary, deoxyschizandrin can effectively rescue the symptoms of DSS-induced ulcerative colitis in mice by inhibiting inflammation. T cell infiltration and apoptosis in the colon, suggesting that deoxyschizandrin could be a potential drug in treating ulcerative colitis.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011083 Polycyclic Compounds Compounds which contain two or more rings in their structure. Compounds, Polycyclic
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
November 2023, Food research international (Ottawa, Ont.),
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
July 2019, International immunopharmacology,
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
December 2018, Journal of agricultural and food chemistry,
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
May 2022, Food & function,
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
January 2020, Frontiers in pharmacology,
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
August 2005, International journal of food microbiology,
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
July 2020, Food & function,
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
January 2023, Frontiers in pharmacology,
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
May 2010, Archives of medical research,
Wen-Feng Zhang, and Yan Yang, and Xin Su, and Da-Yan Xu, and Yu-Li Yan, and Qiao Gao, and Ming-Hua Duan
December 2021, Bioengineered,
Copied contents to your clipboard!